You are viewing the site in preview mode

Skip to main content

Table 1 Association between clinicopathological features, STOML2 expression and survival

From: STOML2 potentiates metastasis of hepatocellular carcinoma by promoting PINK1-mediated mitophagy and regulates sensitivity to lenvatinib

Factors OS TTR
Univariate P value Multivariate Univariate P value Multivariate
HR 95% CI P value HR 95% CI P value
Hepatitis B e antigen: positive versus negative 0.038 1.547 1.033–2.318 0.034 0.013 1.709 1.169–2.498 0.006
AFP (≤ 400 versus > 400 ng/ml) 0.024    NS 0.005    NS
Tumor differentiation: low versus high 0.027 1.920 1.192–3.095 0.007 0.235    NA
Vascular invasión(yes vs. no)  < 0.001    NS 0.001    NS
Tumor size (≤ 5 vs. > 5 cm)  < 0.001 2.963 1.864–4.710  < 0.001  < 0.001 2.108 1.392–3.193  < 0.001
Tumor number (single versus. multiple) 0.004    NS 0.008    NS
UICC TNM stage (I vs. II vs. IIIA)  < 0.001 1.703 1.274–2.275  < 0.001  < 0.001 1.548 1.186–2.022 0.001
STOML2 (low vs. high) 0.001 1.596 1.057–2.410 0.026 0.003 1.638 1.120–2.395 0.011
  1. OS overall survival, TTR time to recurrence, CI, confidence interval, HR hazard ratio, NA not adopted, NS not significant, AFP α-fetoprotein, UICC International Union Against Cancer, TNM tumor-node-metastasis, STOML2 Stomatin-like protein 2